Public Employees Retirement Association of Colorado reduced its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,007 shares of the company’s stock after selling 1,430 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Clorox were worth $1,992,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its stake in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after buying an additional 48,632 shares during the last quarter. Point72 Asset Management L.P. bought a new position in Clorox during the 4th quarter worth $144,844,000. Norges Bank acquired a new position in Clorox during the 4th quarter worth $128,382,000. Parsifal Capital Management LP acquired a new position in Clorox during the 4th quarter worth $128,245,000. Finally, Confluence Investment Management LLC acquired a new position in Clorox during the 1st quarter worth $135,630,000. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the company. DA Davidson reiterated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Citigroup cut their target price on Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Evercore ISI cut their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. UBS Group cut their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Finally, Barclays cut their target price on Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a research report on Friday, July 19th. Six analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $142.13.
Clorox Stock Performance
Shares of NYSE CLX opened at $131.70 on Tuesday. The firm has a market cap of $16.36 billion, a price-to-earnings ratio of 69.37, a P/E/G ratio of 1.98 and a beta of 0.39. The business’s 50-day simple moving average is $133.69 and its 200-day simple moving average is $142.60. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the firm earned $1.51 EPS. Clorox’s revenue for the quarter was down 5.3% compared to the same quarter last year. As a group, equities research analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- How to Calculate Inflation Rate
- Should You Invest in Bonds? Here’s What to Know
- 3 Best Fintech Stocks for a Portfolio Boost
- Why This Manufacturer is Committing to a Massive Buyback Program
- What is an Earnings Surprise?
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.